Latest Breaking News On - Protein sciences - Page 6 : comparemela.com

Accelerating antibody therapy with INTEGRA pipettes

INTEGRA Biosciences has awarded 50 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000 and various lab accessories to UK-based start-up Creasallis, helping to accelerate its pioneering research into improving the penetration of therapeutic antibodies into tumors. Click to read more.

United kingdomJoyce rattiHead of protein sciences at creasallisBabraham research campusUnited kingdom basedCreasallis tumor antibody penetrationProtein sciences

Contrasting Bio-Techne (NASDAQ:TECH) and Genfit (NASDAQ:GNFT)

Bio-Techne (NASDAQ:TECH – Get Free Report) and Genfit (NASDAQ:GNFT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current ratings and […]

United statesUnited kingdomGenoscience pharmaBio techne corporationTechne corporationProtein sciencesGet free reportGiven genfitMiddle eastGreater chinaUrea cycle disorderOrganic acidemia disorderBio techne dailyBio techneNasdaq techStock comparison

BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024

MINNEAPOLIS, Jan. 4, 2024 /PRNewswire/ Bio-Techne Corporation today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and.

United statesMiami beach convention centerNick casaleRicardo jimenezIgnacio nunezDavid hermansonDavid clairJosh ludwigKiromic biopharmaWilson wolfFresenius kabiInvestor relations corporate developmentBio techne protein sciences segmentPrnewswire bio techne corporationBio techne corporationViral solutions for gene therapy

BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J P MORGAN HEALTHCARE CONFERENCE

MINNEAPOLIS, Dec. 21, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Kim Kelderman, current Chief Operating Officer, and Chief Executive Officer effective February 1, 2024, will.

Kim keldermanDavid clairProtein sciences segmentInvestor relations corporate developmentBio techne corporationPrnewswire bio techne corporationTechne corporationChief operating officerChief executive officerHealthcare conferenceInvestor relationsProtein sciencesVice president

Bio-Techne (TECH) Announces Submission Of FDA Drug Master File For Excellerate Gmp Ipsc Expansion Medium Supporting Stem Cell Therapy

Bio-Techne (TECH) Announces Submission Of FDA Drug Master File For Excellerate Gmp Ipsc Expansion Medium Supporting Stem Cell Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bio techne protein sciences segmentDrug administrationBio techne corporationDrug master fileAnimal freeInvestigational new drugProtein sciences